Form 4 for ALNY ALNYLAM PHARMACEUTICALS, INC.
Accepted 2023-02-03 00:00:00 ET · period of report 2023-02-01 · accession 0001735276-23-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-02-03 | 2023-02-02+ | ALNY | Tanguler Tolga | EVP, Chief Commercial Off | S - Sale+OE | $230.19 | -5,025 | 2,246 | -69% | -$1.16M |
| D | 2023-02-03 | 2023-02-01 | ALNY | Tanguler Tolga | EVP, Chief Commercial Off | M - OptEx | $0.00 | +5,025 | 5,025 | New | $0 |
| D | 2023-02-03 | 2023-02-01 | ALNY | Tanguler Tolga | EVP, Chief Commercial Off | M - OptEx | $0.00 | -5,025 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-02 | S | D | 4 | $227.38 | 3,424 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-03 | S | D | 953 | $233.31 | 0 | D | — | — | (F10) The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $233.02 to $233.81. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| 3 | Common | Common Stock | 2023-02-03 | S | D | 1,293 | $232.53 | 953 | D | — | — | (F9) The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $231.94 to $232.90. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| 4 | Common | Common Stock | 2023-02-01 | M | A | 5,025 | $0.00 | 5,025 | D | — | — | |
| 5 | Common | Common Stock | 2023-02-02 | S | D | 73 | $223.97 | 4,952 | D | — | — | (F2) The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $223.42 to $224.25. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| 6 | Common | Common Stock | 2023-02-02 | S | D | 963 | $225.80 | 3,989 | D | — | — | (F3) The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $225.21 to $226.20. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| 7 | Common | Common Stock | 2023-02-02 | S | D | 561 | $226.62 | 3,428 | D | — | — | (F4) The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $226.23 to $227.12. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| 8 | Common | Common Stock | 2023-02-03 | S | D | 128 | $227.68 | 3,296 | D | — | — | (F6) The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $227.63 to $228.38. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| 9 | Common | Common Stock | 2023-02-03 | S | D | 185 | $230.20 | 3,111 | D | — | — | (F7) The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $229.87 to $230.62. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| 10 | Common | Common Stock | 2023-02-03 | S | D | 865 | $231.35 | 2,246 | D | — | — | (F8) The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $230.90 to $231.90. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| 11 | Derivative | Restricted Stock Units | 2023-02-01 | M | D | 5,025 | $0.00 | 0 | D | $0.00 · — to — | 5,025 Common Stock | (F11) Each restricted stock unit represents a contingent right to receive one share of ALNY common stock. (F12) On February 1, 2021 the reporting person received 10,051 restricted stock units, one-half of which vested on the first anniversary of the grant date, and one-half of which vested on the second anniversary of the grant date (February 1, 2023). |